Home›Companies›Biotech & Pharma›Aperture Bio

Aperture Bio, Inc.

Updated Oct 27, 2026·Latest SEC filing Sep 26, 2023·Suggest an edit

About Aperture Bio

Aperture Bio is a private company based in Allston, Massachusetts, incorporated in 2022 in Delaware. It has reported $120,000 raised in two offerings on Form D since September 2023. Its chief executive is Laura Kelley.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 15, 2023Sep 26, 2023$100,000fully sold1$100KEquity, DebtRule 506(b)Form D ↗
Aug 21, 2023Sep 25, 2023$20,000fully sold1$20,000Equity, DebtRule 506(b)Form D ↗
Total, two offerings$120,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Aperture Bio's Form D filed Sep 26, 2023.

LK
Laura Kelley
Chief Executive Officer and director
HP
Hannah Peterson
Executive officer and director

Sources

  1. SECAPERTURE BIO, INC. filing history